ALEC
Alector, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.46
−1.99%Margins
Gross margin
-360.9%
EBITDA margin
-777.9%
EBIT margin
-914.6%
Net margin
-850.1%
FCF margin
-1142.6%
1182.1%
Return on equity
-58.1%
Return on assets
-556.4%
Return on invested capital
0.06x
Asset turnover
-$158.2M
Cash from operations
$1.55
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026